Literature DB >> 28396113

Effect of intranasal corticosteroids on allergic airway disease in asthma.

Anne E Dixon1, Mario Castro2, Lynn B Gerald3, Janet T Holbrook4, Robert J Henderson4, Thomas B Casale5, Charles G Irvin6, Kendall Black6, Robert A Wise4, Elizabeth A Sugar4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28396113      PMCID： PMC5503758          DOI： 10.1016/j.jaip.2017.02.022

Source DB:  PubMed          Journal:  J Allergy Clin Immunol Pract


× No keyword cloud information.
  9 in total

1.  Influence of intranasal steroids during the grass pollen season on bronchial responsiveness in children and young adults with asthma and hay fever.

Authors:  B J Thio; G L Slingerland; A M Fredriks; A F Nagelkerke; R A Scheeren; H J Neijens; J J Roord; J E Dankert-Roelse
Journal:  Thorax       Date:  2000-10       Impact factor: 9.139

2.  Ongoing allergic rhinitis impairs asthma control by enhancing the lower airway inflammation.

Authors:  Asako Oka; Kazuto Matsunaga; Tadashi Kamei; Yukihiro Sakamoto; Tsunahiko Hirano; Atsushi Hayata; Keiichiro Akamatsu; Takashi Kikuchi; Masataka Hiramatsu; Tomohiro Ichikawa; Masanori Nakanishi; Yoshiaki Minakata; Nobuyuki Yamamoto
Journal:  J Allergy Clin Immunol Pract       Date:  2013-12-27

3.  No mucosal atrophy and reduced inflammatory cells: active-controlled trial with yearlong fluticasone furoate nasal spray.

Authors:  Wytske J Fokkens; Bas Rinia; Cornelis M van Drunen; Peter W Hellings; Greet Hens; Ad Jansen; Henk Blom; Wei Wu; Diane S Clements; Laurie A Lee; Edward E Philpot
Journal:  Am J Rhinol Allergy       Date:  2012 Jan-Feb       Impact factor: 2.467

4.  Efficacy of nasal mometasone for the treatment of chronic sinonasal disease in patients with inadequately controlled asthma.

Authors:  Anne E Dixon; Mario Castro; Rubin I Cohen; Lynn B Gerald; Janet T Holbrook; Charles G Irvin; Shyam Mohapatra; Stephen P Peters; Sobharani Rayapudi; Elizabeth A Sugar; Robert A Wise
Journal:  J Allergy Clin Immunol       Date:  2014-08-28       Impact factor: 10.793

5.  Lower airway disease in asthmatics with and without rhinitis.

Authors:  Anne E Dixon; Danielle M Raymond; Benjamin T Suratt; Lorraine M Bourassa; Charles G Irvin
Journal:  Lung       Date:  2008-10-09       Impact factor: 2.584

6.  Criteria to screen for chronic sinonasal disease.

Authors:  Anne E Dixon; Elizabeth A Sugar; S James Zinreich; Raymond G Slavin; Jonathan Corren; Robert M Naclerio; Masaru Ishii; Rubin I Cohen; Ellen D Brown; Robert A Wise; Charles G Irvin
Journal:  Chest       Date:  2009-07-06       Impact factor: 9.410

7.  Asthma Control Test: reliability, validity, and responsiveness in patients not previously followed by asthma specialists.

Authors:  Michael Schatz; Christine A Sorkness; James T Li; Philip Marcus; John J Murray; Robert A Nathan; Mark Kosinski; Trudy B Pendergraft; Priti Jhingran
Journal:  J Allergy Clin Immunol       Date:  2006-03       Impact factor: 10.793

8.  Randomized placebo-controlled trial comparing fluticasone aqueous nasal spray in mono-therapy, fluticasone plus cetirizine, fluticasone plus montelukast and cetirizine plus montelukast for seasonal allergic rhinitis.

Authors:  G Di Lorenzo; M L Pacor; M E Pellitteri; G Morici; A Di Gregoli; C Lo Bianco; V Ditta; N Martinelli; G Candore; P Mansueto; G B Rini; R Corrocher; C Caruso
Journal:  Clin Exp Allergy       Date:  2004-02       Impact factor: 5.018

Review 9.  Mometasone furoate nasal spray: a systematic review.

Authors:  Desiderio Passali; Maria Carla Spinosi; Anna Crisanti; Luisa Maria Bellussi
Journal:  Multidiscip Respir Med       Date:  2016-05-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.